You searched for "regulation"

3439 results found

Can OCT predict Alzheimer’s disease?

Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Can OCT predict Alzheimer’s disease? In 1986 Hinton et al. demonstrated evidence of optic nerve degeneration...

Centre for Sight Marks 30 Years with Ophthalmology Conference on the Future of Vision Care

Centre for Sight is celebrating three decades at the forefront of ophthalmology with a landmark conference set to bring together some of the world’s leading eye care specialists. Titled “30 Years of Vision: Crafting the Next Decade,” the one-day, invitation-led...

AlloDerm for correction of lower lid retraction

This is a retrospective review of 95 eyes of 54 patients undergoing orbital decompression for Graves’ orbitopathy. All patients had a swinging eyelid approach across the whole of the lower lid. Thirty-six eyes also had insertion of a 0.3mm thick...

Validation of a vision screening service according to AFSOP recommendations

This study evaluated the accuracy of the diagnostic parameters used in the French Association for Paediatric Ophthalmology and Strabismus (AFSOP) screening protocol performed by an orthoptist in relation to the reference standard ophthalmology examination. The study also evaluated parent satisfaction...

Retinoblastoma management update (part 1): clinical features, diagnosis and genetics

The first of a two part series, this article will discuss the clinical features, diagnosis and genetic aspects of retinoblastoma. Manoj Parulekar is based at Birmingham Children’s Hospital, one of the two designated national retinoblastoma and paediatric ocular oncology treatment...

Intravitreal dexamethasone implant for recurrent CMO secondary to IGS

In this prospective study the authors present the data obtained on the efficacy and safety of the dexamethasone implant (0.7 mg) in the treatment of recurrent cystoid macular oedema (PCME) due to Irvine–Gass syndrome in patients with uncomplicated pseudophakia (off-label...

VISION 2020 LINKS Programme: building capacity for eye care services in Nigeria through leadership and skills development

The Lagos-Bolton VISION 2020 LINK started in December 2011. It is one of 29 LINKS now running in the VISION 2020 LINKS Programme [1]. Nigeria is the most populous country in Africa, with a current population of 178 million, projected...

Learning to see the bigger picture: Reflections from a cataract surgery course in the Middle East

Alcon, the Swiss-American company specialising in eyecare equipment, inaugurated their Alcon Experience Centre (AEC) in Jeddah, Saudi Arabia. AEC is an eye education and training centre for students and eyecare professionals. This is the first AEC catering to the Middle...

Corneal transplantation in the United Kingdom: are we blind to the challenges that still exist after the Organ Donation Bill?

Corneal transplantation (CT) is a significant treatment option for a huge number of patients in the United Kingdom (UK) [1]. For an individual, CT results in a substantial improvement in quality of life. Penetrating keratoplasty with full thickness grafting has...

Considerations in the management of retinal disorders

Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...

How the thinking machine is transforming the retinal landscape

Regulatory approval of the first two therapeutic substances for the management of geographic atrophy (GA) secondary to age-related macular degeneration has been a major breakthrough. The authors explored the issue surrounding the lack of agreed therapeutic standards and diagnostic tools...

The bionic eye – behind the headlines

Multiple visual prosthetic projects and other vision regeneration initiatives being tested in preclinical and clinical development worldwide illustrate continuing progress and opportunities in addressing profound blindness from hereditary retinal diseases and other causes (Table 1). Three implantable bionic vision systems...